Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 24, Iss. 4, 2008-01 ,pp. : 207-213

Informa Healthcare

Access to resources Recommend Favorite

Discriminative Capacity of Calcaneal Quantitative Ultrasound and of Osteoporosis and Fracture Risk Factors in Postmenopausal Women with Osteoporotic Fractures

By Hernández J. L.  

Calcified Tissue International, Vol. 74, Iss. 4, 2004-04 ,pp. : 357-365

Springer Publishing Company

Access to resources Recommend Favorite

The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis

By Karadag-Saygi Evrim   Akyuz Gulseren   Bizargity Peyman   Ay Pinar  

Gynecological Endocrinology, Vol. 27, Iss. 12, 2011-12 ,pp. : 1033-1036

Informa Healthcare

Access to resources Recommend Favorite

Evidence that Treatment with Risedronate in Women with Postmenopausal Osteoporosis Affects Bone Mineralization and Bone Volume

By Fratzl Peter   Roschger Paul   Fratzl-Zelman Nadja   Paschalis Eleftherios   Phipps Roger   Klaushofer Klaus  

Calcified Tissue International, Vol. 81, Iss. 2, 2007-08 ,pp. : 73-80

Springer Publishing Company

Access to resources Recommend Favorite

Glucocorticoid therapy as a significant risk factor for osteoporosis and fractures in an Italian postmenopausal population

By Villa Paola  

Gynecological Endocrinology, Vol. 29, Iss. 7, 2013-07 ,pp. : 678-682

Informa Healthcare

Access to resources Recommend Favorite